China Biotech Services Holdings

China Biotech Services Holdings, headquartered in China, operates in the Medical, precision and optical instruments, watches and clocks industry. In 2023, the company's total reported carbon emissions were 843,000 kg CO2e. This included 647,000 kg CO2e from Scope 2 emissions and 63,700 kg CO2e from Scope 3 emissions, which encompassed business travel (48,000 kg CO2e) and waste generated in operations (5,600 kg CO2e). The company did not disclose Scope 1 emissions for 2023.

In 2022, China Biotech Services Holdings' total reported carbon emissions were approximately 11.27 million kg CO2e. This comprised approximately 11.24 million kg CO2e from Scope 2 emissions and 33,700 kg CO2e from Scope 3 emissions, including business travel (15,600 kg CO2e) and waste generated in operations (11,600 kg CO2e).

Looking further back, in 2021, the company's total reported emissions were 238,000 kg CO2e, with 38,000 kg CO2e from Scope 1, 159,000 kg CO2e from Scope 2, and 40,900 kg CO2e from Scope 3. In 2020, total emissions were 465,000 kg CO2e, including 35,000 kg CO2e from Scope 1, 339,000 kg CO2e from Scope 2, and 30,900 kg CO2e from Scope 3. For 2019, total emissions were 541,000 kg CO2e, with 30,000 kg CO2e from Scope 1, 467,000 kg CO2e from Scope 2, and 43,700 kg CO2e from Scope 3. No emissions data was available for 2018.

China Biotech Services Holdings has not publicly disclosed any specific reduction targets or climate pledges.